Physicians Realty Trust (NYSE:DOC) shares advanced 1.08% in last trading session and ended the day at $15.95. DOC Gross Margin is 77.20% and its has a return on assets of 0.60%. Physicians Realty Trust (NYSE:DOC) quarterly performance is 10.90%.
Physicians Realty Trust (NYSE:DOC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday, MarketBeat Ratings reports.
Keurig Green Mountain, Inc. (NASDAQ:GMCR) ended the last trading day at $89.11. Company weekly volatility is calculated as 0.62% and price to cash ratio as 223.80. Keurig Green Mountain, Inc. (NASDAQ:GMCR) showed a weekly performance of -0.60%.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Keurig Green Mountain, Inc. (NASDAQ: GMCR) (“Keurig Green Mountain” or the “Company”) relating to the proposed buyout of the Company by JAB Holding Company.
On 15 December, AudioCodes Ltd. (NASDAQ:AUDC) shares advanced 3.97% and was closed at $4.19. AUDC EPS growth in last 5 year was 14.90%. AudioCodes Ltd. (NASDAQ:AUDC) year to date (YTD) performance is -7.71%.
AudioCodes (NASDAQ: AUDC), announced that Mr. Shabtai Adlersberg, President and Chief Executive Officer, attended the Cowen and Company’s Networking & Cybersecurity Summit on December 15th, 2015. The summit held at the W Hotel on Lexington Ave in New York City.
Adaptimmune Therapeutics plc (NASDAQ:ADAP) shares fell -1.88% in last trading session and ended the day at $8.88. ADAP has a return on assets of -39.20%. Adaptimmune Therapeutics plc (NASDAQ:ADAP) quarterly performance is -29.80%.
Adaptimmune Therapeutics plc (NASDAQ:ADAP) entered into a partnership agreement with Universal Cells, a small Seattle-based biotech specializing in gene editing. Universal uses a nuclease-free approach to re-engineer stem cells into therapies created with donor cells.
Mallinckrodt PLC (NYSE:MNK) caters to the Healthcare space. It has a net profit margin of 12.40% and weekly performance is 2.07%. On the last day of trading company shares ended up at $73.64. Mallinckrodt PLC (NYSE:MNK) distance from 50-day simple moving average (SMA50) is 11.88%.
On 7 December, Mallinckrodt plc (MNK), held its investor briefing in New York City with presentations by Mark Trudeau, President and Chief Executive Officer of Mallinckrodt and Steve Romano, M.D., Chief Scientific Officer.
Leave a Reply